Insider Trading & Ownership - GLYCOMIMETICS INC (GLYC)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for GLYCOMIMETICS INC
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-21
Purchase
2023-09-25
4:21 pm
GLYCOMIMETICS INCGLYCRock Edwin
Chief Medical Officer
65,403$1.38$90,256375,403
(Direct)
View
2023-05-17
Sale
2023-05-18
4:27 pm
GLYCOMIMETICS INCGLYCHahn Brian M.
SVP Finance, CFO
3,700$1.95$7,21553,143
(Direct)
View
2023-05-10
Purchase
2023-05-11
5:08 pm
GLYCOMIMETICS INCGLYCJUNIUS DANIEL M
Director
30,000$1.56$46,80093,250
(Direct)
View
2023-05-08
Purchase
2023-05-09
5:00 pm
GLYCOMIMETICS INCGLYCJohnson Bruce S
SVP & Chief Commercial Officer
13,500$1.57$21,195138,980
(Direct)
View
2023-02-24
Purchase
2023-02-28
5:33 pm
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Wittouck Amaury
Stichting Administratiekantoor Westend
Invus Public Equities Advisors LLC
10% Owner
100,000$1.7$170,0008,589,064
(Direct)
View
2023-02-21
Purchase
2023-02-23
6:23 pm
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Wittouck Amaury
Stichting Administratiekantoor Westend
Invus Public Equities Advisors LLC
10% Owner
400,000$1.7806$712,2558,489,064
(Direct)
View
2023-02-15
Purchase
2023-02-17
5:29 pm
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Wittouck Amaury
Stichting Administratiekantoor Westend
Invus Public Equities Advisors LLC
10% Owner
1,515,266$1.9983$3,027,9298,089,064
(Direct)
View
2023-02-09
Purchase
2023-02-13
5:45 pm
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Wittouck Amaury
Stichting Administratiekantoor Westend
Invus Public Equities Advisors LLC
10% Owner
11,451$3.2419$37,1236,573,798
(Direct)
View
2023-01-25
Sale
2023-01-27
5:15 pm
GLYCOMIMETICS INCGLYCSANDELL SCOTT D
10% Owner
3,652,016$3.1447$11,484,5152,237,196
(Indirect)
View
2023-01-05
Sale
2023-01-06
6:35 pm
GLYCOMIMETICS INCGLYCSANDELL SCOTT D
10% Owner
71,362$2.7586$196,8593,881,933
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-29
Option Award
2024-04-02
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCJUNIUS DANIEL M
Director
5,209$398,459
(Direct)
View
2024-03-29
Option Award
2024-04-02
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
3,334$3659,095
(Direct)
View
2024-03-29
Option Award
2024-04-02
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCGoldberg Mark Alan
Director
4,584$336,325
(Direct)
View
2024-01-12
Option Award
2024-01-17
4:05 pm
N/A
2034-01-11
GLYCOMIMETICS INCGLYCJohnson Bruce S
SVP & Chief Commercial Officer
250,000$0250,000
(Direct)
View
2024-01-12
Option Award
2024-01-17
4:05 pm
N/A
2034-01-11
GLYCOMIMETICS INCGLYCSemerjian Harout
Chief Executive Officer
695,000$0695,000
(Direct)
View
2024-01-12
Option Award
2024-01-17
4:05 pm
N/A
2034-01-11
GLYCOMIMETICS INCGLYCRock Edwin
Chief Medical Officer
250,000$0250,000
(Direct)
View
2024-01-12
Option Award
2024-01-17
4:05 pm
N/A
2034-01-11
GLYCOMIMETICS INCGLYCRath Chinmaya
SVP and Chief Business Officer
250,000$0250,000
(Direct)
View
2024-01-12
Option Award
2024-01-17
4:05 pm
N/A
2034-01-11
GLYCOMIMETICS INCGLYCHahn Brian M.
SVP Finance, CFO
250,000$0250,000
(Direct)
View
2023-12-29
Option Award
2024-01-02
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCAndrews Patricia S
Director
5,191$2.3658,608
(Direct)
View
2023-12-29
Option Award
2024-01-02
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
4,238$2.36657,502
(Direct)
View
2023-12-29
Option Award
2024-01-02
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCGoldberg Mark Alan
Director
5,827$2.3631,741
(Direct)
View
2023-09-30
Option Award
2023-10-03
4:15 pm
N/A
N/A
GLYCOMIMETICS INCGLYCGoldberg Mark Alan
Director
9,167$1.525,914
(Direct)
View
2023-09-30
Option Award
2023-10-03
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCAndrews Patricia S
Director
8,167$1.553,417
(Direct)
View
2023-09-30
Option Award
2023-10-03
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
6,667$1.5653,264
(Direct)
View
2023-06-01
Exercise
2023-06-02
4:10 pm
N/A
2032-05-17
GLYCOMIMETICS INCGLYCKoenig Scott
Director
21,000$036,750
(Direct)
View
2023-06-01
Exercise
2023-06-02
4:10 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKoenig Scott
Director
21,000$0.636,750
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:27 pm
N/A
2033-05-18
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
35,000$035,000
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:25 pm
N/A
2033-05-18
GLYCOMIMETICS INCGLYCJUNIUS DANIEL M
Director
35,000$035,000
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:24 pm
N/A
2033-05-18
GLYCOMIMETICS INCGLYCKoenig Scott
Director
35,000$035,000
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:23 pm
N/A
2033-05-18
GLYCOMIMETICS INCGLYCGoldberg Mark Alan
Director
35,000$035,000
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:21 pm
N/A
2033-05-18
GLYCOMIMETICS INCGLYCPEARSON TIMOTHY R
Director
35,000$035,000
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:20 pm
N/A
2033-05-18
GLYCOMIMETICS INCGLYCAndrews Patricia S
Director
35,000$035,000
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:18 pm
N/A
2033-05-18
GLYCOMIMETICS INCGLYCJackson Scott Thomas
Director
35,000$035,000
(Direct)
View

Ownership
2023-03-31
4:36 pm
N/A
N/A
GLYCOMIMETICS INCGLYCRath Chinmaya
SVP and Chief Business Officer
0$0311,178
(Direct)
View

Ownership
2023-03-31
4:34 pm
N/A
N/A
GLYCOMIMETICS INCGLYCJohnson Bruce S
SVP & Chief Commercial Officer
0$0560,480
(Direct)
View

Ownership
2023-02-13
5:40 pm
N/A
N/A
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Wittouck Amaury
Stichting Administratiekantoor Westend
Invus Public Equities Advisors LLC
10% Owner
0$06,562,347
(Direct)
View
2022-02-15
Ownership
2023-02-06
4:13 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
19,141$0646,597
(Direct)
View

Ownership
2023-02-06
4:13 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
0$0646,597
(Indirect)
View
2023-01-27
Exercise
2023-01-30
4:13 pm
N/A
2031-05-17
GLYCOMIMETICS INCGLYCKoenig Scott
Director
10,500$015,750
(Direct)
View
2023-01-27
Exercise
2023-01-30
4:13 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKoenig Scott
Director
10,500$2.5515,750
(Direct)
View
2023-01-19
Option Award
2023-01-20
4:08 pm
N/A
2033-01-18
GLYCOMIMETICS INCGLYCHahn Brian M.
SVP Finance, CFO
246,300$0246,300
(Direct)
View
2023-01-19
Option Award
2023-01-20
4:04 pm
N/A
2033-01-18
GLYCOMIMETICS INCGLYCSemerjian Harout
Chief Executive Officer
651,200$0651,200
(Direct)
View
2023-01-19
Option Award
2023-01-20
4:02 pm
N/A
2033-01-18
GLYCOMIMETICS INCGLYCRock Edwin
Chief Medical Officer
244,800$0244,800
(Direct)
View
Goto 0, 1, 2, Next